hepatitis C

What Is Next For The Hepatitis C Space?
Seeking Alpha
Fri, 06/13/14 - 11:05 am
hepatitis C
Conatus Pharmaceuticals
Gilead Sciences
Merck
Idenix
Why Did Merck Pay Such A Huge Premium For Idenix
Seeking Alpha
Wed, 06/11/14 - 08:12 pm
Merck
Idenix
hepatitis C
M&A
Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
Seeking Alpha
Tue, 06/10/14 - 07:19 pm
Idenix
Merck
M&A
hepatitis C
Sovaldi
Gilead Sciences
Achillion Hep C Drug Update is Well Timed
TheStreet.com
Tue, 06/10/14 - 09:54 am
Achillion
hepatitis C
sovaprevir
Merck
Idenix
Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony?
Seeking Alpha
Mon, 06/9/14 - 07:53 pm
Sovaldi
Gilead Sciences
hepatitis C
Gilead Down On Merck-Idenix Deal, But Little To Fear
Seeking Alpha
Mon, 06/9/14 - 02:50 pm
Gilead Sciences
Merck
Idenix
hepatitis C
M&A
Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Merck
Gilead Sciences
Idenix
M&A
hepatitis C
Achillion Pharma Might be Next Hep C Takeout Target
TheStreet.com
Mon, 06/9/14 - 09:40 am
Achillion
hepatitis C
M&A
JNJ
AbbVie
Merck
Idenix
Why Merck Just Spent $4 Billion On New Drugs For Hepatitis C
Forbes
Mon, 06/9/14 - 09:24 am
Merck
hepatitis C
M&A
Idenix
Merck to Buy Hepatitis-Drug Maker Idenix
Bloomberg
Mon, 06/9/14 - 11:59 am
Idenix
Merck
M&A
hepatitis C
Medicare opens door wide for Gilead's $84K hep C drug Sovaldi
Fierce Pharma
Wed, 06/4/14 - 03:14 pm
Medicare
Gilead
hepatitis C
Sovaldi
What Price Innovation? The Sovaldi Saga
Forbes
Thu, 05/29/14 - 09:43 am
innovation
Sovaldi
Gilead Sciences
drug pricing
hepatitis C
Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too
Fierce Pharma
Tue, 05/20/14 - 11:47 am
Sovaldi
side effects
hepatitis C
Gilead Sciences
A Physician Compares Gilead's And AbbVie's Hepatitis C Products
Seeking Alpha
Mon, 05/12/14 - 11:15 am
Gilead Sciences
AbbVie
hepatitis C
Sovaldi
physicians
Humira
J&J /Gilead HCV Combo Drug Filed
Yahoo/Zacks.com
Thu, 05/8/14 - 05:20 pm
JNJ
Gilead Sciences
hepatitis C
Olysio
Sovaldi
Gilead Sciences - Sovaldi's Pricing In A New Perspective
Seeking Alpha
Mon, 05/5/14 - 05:02 pm
Gilead Sciences
Sovaldi
hepatitis C
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Merck
Bristol-Myers Squibb
Gilead Sciences
Roche
MK-3475
hepatitis C
Why Sovaldi shouldn't cost $84,000
Modern Healthcare
Sun, 05/4/14 - 11:59 am
Sovaldi
hepatitis C
hepatitis
Gilead Sciences
Vertex's Sales Plunge 64% as It Refocuses Its Pipeline on Cystic Fibrosis Therapies
Motley Fool
Thu, 05/1/14 - 10:15 pm
cystic fibrosis
Vertex Pharmaceuticals
hepatitis C
earnings
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Yahoo/Reuters
Wed, 04/30/14 - 01:08 pm
hepatitis C
drug costs
Wellpoint
Sovaldi
Gilead Sciences

Pages